Prosecution Insights
Last updated: April 19, 2026

Prothena Biosciences Limited

5 pending office actions

Portfolio Summary

5
Total Pending OAs
1
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18305109 Tau Immunotherapy SZPERKA, MICHAEL EDWARD 1641 Non-Final OA Apr 21, 2023
18245533 ALPHA-SYNUCLEIN VACCINE FOR THE TREATMENT OF SYNUCLEINOPATHIES HOWARD, ZACHARY C 1674 Non-Final OA Mar 15, 2023
18170890 ANTIBODIES RECOGNIZING TAU HADDAD, MAHER M 1641 Non-Final OA Feb 17, 2023
18145588 ANTIBODIES RECOGNIZING SORTILIN LI, RUIXIANG 1674 Final Rejection Dec 22, 2022
17429288 ANTIBODIES RECOGNIZING TAU GUSTILO, ESTELLA M 1646 Non-Final OA Aug 06, 2021

Managing Prothena Biosciences Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month